| Mrs Frances Maria Abeyta, | |
|
801 Encino Pl Ne Ste D7, Albuquerque, NM 87102-2644 | |
| (505) 207-6526 | |
| Not Available |
| Full Name | Mrs Frances Maria Abeyta |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 801 Encino Pl Ne Ste D7, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164209862 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WG0000X | Registered Nurse - General Practice | RN-89669 (New Mexico) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 77117 (New Mexico) | Primary |
| Entity Name | Ribera Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639726920 PECOS PAC ID: 3072844158 Enrollment ID: O20191004000971 |
News Archive
A new Tel Aviv University drug, based on an older generation antibiotic, may provide doctors with an effective and innovative method of treating colon cancer in both its incipient and full-blown stages ― and minimize the need for painful, uncomfortable colonoscopies and surgical polyp removal.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously debilitating and potentially lethal disease.
In its early stages, prostate cancer requires androgens (hormones that promote the development and maintenance of male sex characteristics) for growth, and current first-line therapies target the receptor for these hormones to slow cancer's development and spread.
Minnetronix, a medical device design and manufacturing firm, is proud to announce the appointment of Charles Garcia, Business Development Manager, as President of the Twin Cities Professional Chapter of the Society of Hispanic Professional Engineers (SHPE).
Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced that it has expanded its ResponseDX: Lung genetic test panel to detect the presence of EML4-ALK gene variants in lung cancer patients. EML4-ALK fusion genes are present in about four percent of tumors from patients with non-small cell lung cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Frances Maria Abeyta, 8513 4th St Nw, Los Ranchos, NM 87114-1401 Ph: (505) 206-8144 | Mrs Frances Maria Abeyta, 801 Encino Pl Ne Ste D7, Albuquerque, NM 87102-2644 Ph: (505) 207-6526 |
News Archive
A new Tel Aviv University drug, based on an older generation antibiotic, may provide doctors with an effective and innovative method of treating colon cancer in both its incipient and full-blown stages ― and minimize the need for painful, uncomfortable colonoscopies and surgical polyp removal.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously debilitating and potentially lethal disease.
In its early stages, prostate cancer requires androgens (hormones that promote the development and maintenance of male sex characteristics) for growth, and current first-line therapies target the receptor for these hormones to slow cancer's development and spread.
Minnetronix, a medical device design and manufacturing firm, is proud to announce the appointment of Charles Garcia, Business Development Manager, as President of the Twin Cities Professional Chapter of the Society of Hispanic Professional Engineers (SHPE).
Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced that it has expanded its ResponseDX: Lung genetic test panel to detect the presence of EML4-ALK gene variants in lung cancer patients. EML4-ALK fusion genes are present in about four percent of tumors from patients with non-small cell lung cancer.
› Verified 6 days ago
Mrs. Kristell L Michael, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Us Air Force 377 Mdg/sghc 2050a Second Street Se, Albuquerque, NM 87117 Phone: 505-846-3562 Fax: 334-953-8607 | |
Mr. Michael Alan Wallace, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8210 Louisiana Blvd Ne, Suite C, Albuquerque, NM 87113 Phone: 505-858-1222 Fax: 505-858-1224 | |
Ms. Maureen Kolomeir, RN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5345 Wyoming Blvd, Suite 101, Albuquerque, NM 87109 Phone: 505-856-6898 Fax: 505-292-1574 | |
Patricia J Miller, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Care Campus, 5901 Zuni Rd Se, Albuquerque, NM 87108 Phone: 505-321-4269 | |
Mrs. Jessika Junick, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3825 Eubank Blvd Ne Ste A, Albuquerque, NM 87111 Phone: 505-292-8575 Fax: 505-292-8409 | |
Phyllis Annette Ingham, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1100 Lead Ave Se, Albuquerque, NM 87106 Phone: 505-224-7000 | |
Debra Vaccaro, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3500 Comanche Rd Ne Ste C, Albuquerque, NM 87107 Phone: 505-998-7200 Fax: 505-998-7220 |